Risk factors and prognostic impact of new decompensated events in hospitalized patients with decompensated cirrhosis

被引:0
作者
Lan, Yan [1 ,2 ]
Yu, Yue [1 ]
Zhang, Xiuding [1 ]
Xu, Xianbin [1 ]
Yu, Xia [1 ]
Tu, Huilan [1 ]
Ye, Shaoheng [1 ]
Weng, Haoda [1 ]
Shi, Yu [1 ]
Sheng, Jifang [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Collaborat Innovat Ctr Diag & Treatment Infect Dis, 79 Qingchun Rd, Hangzhou 310003, Peoples R China
[2] Lishui Peoples Hosp, Dept Gastroenterol, Lishui 323000, Peoples R China
关键词
Decompensated cirrhosis; New decompensated events; MELD score; Prognosis; First decompensation; CHRONIC LIVER-FAILURE; INDICATORS; DISTINCT;
D O I
10.1186/s12876-024-03494-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundDecompensated cirrhosis (DC) is prone to recurrent episodes of decompensation following the initial event. This study aimed to identify the risk factors for subsequent decompensation and assess their impact on the outcomes of patients hospitalized for DC. MethodsPatients with DC were divided into two groups based on the occurrence of new decompensated events during hospitalization. Logistic regression analysis was employed to identify risk factors for new decompensation. The Cox proportional hazards model was used to evaluate the relationship between new decompensation and short-term mortality risk in these patients. ResultsThe study cohort consisted of 339 patients with DC, with a median age of 57 years. During hospitalization, 83 patients (24.5%) experienced new decompensated events, with bacterial infections (BIs) being the most common (n = 46, 13.6%). Multivariate analysis revealed that the Model for End-Stage Liver Disease (MELD) score at admission (OR = 1.06, 95% CI: 1.02-1.11, P = 0.005) was the sole risk factor for new decompensation during hospitalization. Patients who experienced new decompensation had significantly higher 28-day (28.9% vs. 7.0%, P < 0.001) and 90-day (33.7% vs. 15.2%, P < 0.001) transplant-free mortality compared to those who did not. After adjusting for white cell count, C-reactive protein, and MELD score, new decompensation during hospitalization was identified as an independent risk factor for 28-day and 90-day mortality (HR = 2.63, 95% CI: 1.42-4.87, P = 0.002 and HR = 1.73, 95% CI: 1.04-2.88, P = 0.033, respectively). ConclusionsPatients with high MELD scores are susceptible to new decompensation during hospitalization, and the occurrence of new decompensation adversely affects short-term mortality in patients with DC.
引用
收藏
页数:10
相关论文
共 28 条
  • [1] The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis
    Arroyo, Vicente
    Angeli, Paolo
    Moreau, Richard
    Jalan, Rajiv
    Claria, Joan
    Trebicka, Jonel
    Fernandez, Javier
    Gustot, Thierry
    Caraceni, Paolo
    Bernardi, Mauro
    [J]. JOURNAL OF HEPATOLOGY, 2021, 74 (03) : 670 - 685
  • [2] Acute-on-Chronic Liver Failure
    Arroyo, Vicente
    Moreau, Richard
    Jalan, Rajiv
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22) : 2137 - 2145
  • [3] Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis
    Arvaniti, Vasiliki
    D'Amico, Gennaro
    Fede, Giuseppe
    Manousou, Pinelopi
    Tsochatzis, Emmanuel
    Pleguezuelo, Maria
    Burroughs, Andrew Kenneth
    [J]. GASTROENTEROLOGY, 2010, 139 (04) : 1246 - +
  • [4] Second Infections Independently Increase Mortality in Hospitalized Patients With Cirrhosis: The North American Consortium for the Study of End-Stage Liver Disease (NACSELD) Experience
    Bajaj, Jasmohan S.
    O'Leary, Jacqueline G.
    Reddy, K. Rajender
    Wong, Florence
    Olson, Jody C.
    Subramanian, Ram M.
    Brown, Geri
    Noble, Nicole A.
    Thacker, Leroy R.
    Kamath, Patrick S.
    [J]. HEPATOLOGY, 2012, 56 (06) : 2328 - 2335
  • [5] Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
    Balcar, Lorenz
    Tonon, Marta
    Semmler, Georg
    Calvino, Valeria
    Hartl, Lukas
    Incicco, Simone
    Jachs, Mathias
    Bauer, David
    Hofer, Benedikt Silvester
    Gambino, Carmine Gabriele
    Accetta, Antonio
    Brocca, Alessandra
    Trauner, Michael
    Mandorfer, Mattias
    Piano, Salvatore
    Reiberger, Thomas
    Baveno Cooperation EASL consortium
    [J]. JHEP REPORTS, 2022, 4 (08)
  • [6] Novel perspectives in the management of decompensated cirrhosis
    Bernardi, Mauro
    Caraceni, Paolo
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (12) : 753 - 764
  • [7] Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
    Caraceni, Paolo
    Riggio, Oliviero
    Angeli, Paolo
    Alessandria, Carlo
    Neri, Sergio
    Foschi, Francesco G.
    Levantesi, Fabio
    Airoldi, Aldo
    Boccia, Sergio
    Svegliati-Baroni, Gianluca
    Fagiuoli, Stefano
    Romanelli, Roberto G.
    Cozzolongo, Raffaele
    Di Marco, Vito
    Sangiovanni, Vincenzo
    Morisco, Filomena
    Toniutto, Pierluigi
    Tortora, Annalisa
    De Marco, Rosanna
    Angelico, Mario
    Cacciola, Irene
    Elia, Gianfranco
    Federico, Alessandro
    Massironi, Sara
    Guarisco, Riccardo
    Galioto, Alessandra
    Ballardini, Giorgio
    Rendina, Maria
    Nardelli, Silvia
    Piano, Salvatore
    Elia, Chiara
    Prestianni, Loredana
    Cappa, Federica Mirici
    Cesarini, Lucia
    Simone, Loredana
    Pasquale, Chiara
    Cavallin, Marta
    Andrealli, Alida
    Fidone, Federica
    Ruggeri, Matteo
    Roncadori, Andrea
    Baldassarre, Maurizio
    Tufoni, Manuel
    Zaccherini, Giacomo
    Bernardi, Mauro
    [J]. LANCET, 2018, 391 (10138) : 2417 - 2429
  • [8] Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models
    Choudhury, A.
    Jindal, A.
    Maiwall, R.
    Sharma, M. K.
    Sharma, B. C.
    Pamecha, V.
    Mahtab, M.
    Rahman, S.
    Chawla, Y. K.
    Taneja, S.
    Tan, S. S.
    Devarbhavi, H.
    Duan, Z.
    Yu, Chen
    Ning, Q.
    Jia, Ji Dong
    Amarapurkar, D.
    Eapen, C. E.
    Goel, A.
    Hamid, S. S.
    Butt, A. S.
    Jafri, W.
    Kim, D. J.
    Ghazinian, H.
    Lee, G. H.
    Sood, Ajit
    Lesmana, L. A.
    Abbas, Z.
    Shiha, G.
    Payawal, D. A.
    Dokmeci, A. K.
    Sollano, J. D.
    Carpio, G.
    Lau, G. K.
    Karim, F.
    Rao, P. N.
    Moreau, R.
    Jain, P.
    Bhatia, P.
    Kumar, G.
    Sarin, S. K.
    [J]. HEPATOLOGY INTERNATIONAL, 2017, 11 (05) : 461 - 471
  • [9] Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
    D'Amico, G
    Garcia-Tsao, G
    Pagliaro, L
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 (01) : 217 - 231
  • [10] Further decompensation in cirrhosis. Results of a large multicenter cohort study supporting Baveno VII statements
    D'Amico, Gennaro
    Zipprich, Alexander
    Villanueva, Candid
    Sorda, Juan Antonio
    Morillas, Rosa Maria
    Garcovich, Matteo
    Garcia Retortillo, Montserrat
    Martinez, Javier
    Cales, Paul
    D'Amico, Mario
    Dollinger, Matthias
    Garcia-Guix, Marta
    Ballerga, Esteban Gonzalez
    Tsochatzis, Emmanouil
    Cirera, Isabel
    Albillos, Agustin
    Roquin, Guillaume
    Pasta, Linda
    Colomo, Alan
    Daruich, Jorge
    Canete, Nuria
    Boursier, Jerome
    Dallio, Marcello
    Gasbarrini, Antonio
    Iacobellis, Angelo
    Gobbo, Giulia
    Merli, Manuela
    Federico, Alessandro
    Baroni, Gianluca Svegliati
    Pozzoni, Pietro
    Addario, Luigi
    Chessa, Luchino
    Ridola, Lorenzo
    Garcia-Tsao, Guadalupe
    [J]. HEPATOLOGY, 2024, 79 (04) : 869 - 881